Results 1 - 10 of 90 for IMATINIB MESYLATE
  1. Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) ... other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of ...
  2. ... with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal ...
  3. ... whose disease could not be treated successfully with imatinib (Gleevec) or adults who cannot take imatinib. Nilotinib is also used to treat certain types ...
  4. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ... Müller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome ...
  5. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ...
  6. ... Schultheis B, Cross NC, Goldman JM. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with ...
  7. Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
  8. The KIT gene provides instructions for making a member of a protein family called receptor tyrosine kinases. Receptor tyrosine kinases transmit signals from ...
  9. ... no longer benefit from other leukemia medications including imatinib (Gleevec) or in those who cannot take these ...
  10. ... adults who have previously received other medications, including imatinib (Gleevec). Ripretinib is in a class of medications ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next